Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2008: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Research Abstract |
As a results of investigation of clinical background concerning intractable chronic rhinosinusitis, we thought that nasal sinus mucosa differences in reactivity against virus infection exists. We verified whether or not the expression of IFN-induced genes such as IP-10 and I-TAC, compares the before and after the incubation with DNA methyltransferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors. We identified that histone acetylation is involved in transcriptional regulation. We targeted to drug discovery for epigenetic control as effective therapy for intractable chronic rhinosinusitis in the future.
|